Concepedia

Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis

Franziska Scheibe, Lennard Ostendorf, S. Momsen Reincke, Ann‐Christin von Brünneck, Martin Köhnlein, Tobias Alexander, Christian Meisel, Andreas Meisel

Journal of Neurology · 2019 · 69 citations · 11 references

DOI

Concepts

References

11

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

Antonio Palumbo, Asher Chanan‐Khan, Katja Weisel et al. · New England Journal of Medicine · 2016 · 1.5K citations · Full text

, , +17

Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma

Jakub Krejcik, Tineke Casneuf, Inger S. Nijhof et al. · Blood · 2016 · 918 citations · Full text

, , +17

The clinical spectrum of Caspr2 antibody–associated disease

Agnes van Sonderen, Helena Ariño, Mar Petit‐Pedrol et al. · Neurology · 2016 · 433 citations · Full text

, , +16

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus

Tobias Alexander, Ramona Sarfert, Jens Klotsche et al. · Annals of the Rheumatic Diseases · 2015 · 363 citations · Full text

, , +15

Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis

Franziska Scheibe, Annerose Mengel, Siegfried Köhler et al. · Neurology · 2016 · 202 citations

, , +15